109 related articles for article (PubMed ID: 32654796)
1. Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma.
Yangui F; Zaiem A; Antit S; Bellakhal S; Zakhama L; Charfi MR
Therapie; 2021; 76(5):486-488. PubMed ID: 32654796
[No Abstract] [Full Text] [Related]
2. Evaluation of calculating carboplatin dosage in carboplatin-pemetrexed therapy as the first-line therapy for Chinese patients with advanced lung adenocarcinoma.
Zhu Y; Xing P; Wang S; Ma D; Mu Y; Li X; Xu Z; Li J
Thorac Cancer; 2018 Mar; 9(3):400-407. PubMed ID: 29377581
[TBL] [Abstract][Full Text] [Related]
3. A Case of Hepatic Portal Venous Gas in a Patient Treated with Pemetrexed and Carboplatin for Lung Cancer.
Kawaguchi Y; Fujita T; Hanaoka J; Hayashi K
Chemotherapy; 2014; 60(2):88-90. PubMed ID: 25720567
[TBL] [Abstract][Full Text] [Related]
4. Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Grilley-Olson JE; Weiss J; Ivanova A; Villaruz LC; Moore DT; Stinchcombe TE; Lee C; Shan JS; Socinski MA
Clin Lung Cancer; 2018 Jul; 19(4):e481-e487. PubMed ID: 29631965
[TBL] [Abstract][Full Text] [Related]
5. Acute lower limb ischemia complicating pemetrexed and carboplatin combination chemotherapy for malignant pleural mesothelioma.
Valerio S; Bracale UM; Giribono AM; Viviani E; Caioni F; del Guercio L
Ann Ital Chir; 2014 Nov; 85(ePub):. PubMed ID: 25586574
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin, pemetrexed, and pembrolizumab was effective for primary salivary gland-type lung adenocarcinoma diagnosed due to esophageal stricture: A case report.
Kawakado K; Tamura T; Nakanishi M; Makimoto G; Sato Y; Kuyama S
Thorac Cancer; 2021 Sep; 12(18):2513-2516. PubMed ID: 34369074
[TBL] [Abstract][Full Text] [Related]
7. Inflamed actinic keratoses associated with pemetrexed and carboplatin therapy.
Lam J; Ellis SR; Sivamani RK
Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469794
[TBL] [Abstract][Full Text] [Related]
8. Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer.
Karayama M; Inui N; Fujisawa T; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Koshimizu N; Sato M; Toyoshima M; Shirai T; Masuda M; Yamada T; Imokawa S; Suda T
Eur J Cancer; 2016 May; 58():30-7. PubMed ID: 26922170
[TBL] [Abstract][Full Text] [Related]
9. [Safety of Neoadjuvant Bevacizumab plus Pemetrexed and Carboplatin
in Patients with IIIa Lung Adenocarcinoma].
Zhang S; Xu P; Yuan C; Ou W
Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):365-8. PubMed ID: 26104893
[TBL] [Abstract][Full Text] [Related]
10. Pemetrexed anaphylaxis-an unusual suspect.
Carneiro-Leão L; Barzylovych V; Cernadas J
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):320-321. PubMed ID: 29908333
[No Abstract] [Full Text] [Related]
11. A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC.
Huang M; Gong Y; Zhu J; Qin Y; Peng F; Ren L; Ding Z; Liu Y; Cai C; Wang Y; Lu Y
Invest New Drugs; 2020 Apr; 38(2):478-484. PubMed ID: 31231786
[TBL] [Abstract][Full Text] [Related]
12. An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Pemetrexed-Carboplatin versus (Weekly) Paclitaxel-Carboplatin as First-Line Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer.
Yadav A; Malik PS; Khurana S; Jain D; Vishnubhatla S; Yadav M; Pathy S; Mohan A; Kumar L
Oncology; 2021; 99(6):389-396. PubMed ID: 33735884
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients.
Tanaka M; Hattori Y; Ishii T; Tohnai R; Itoh S; Kawa Y; Kono Y; Urata Y; Satouchi M
Respir Investig; 2020 Jul; 58(4):269-274. PubMed ID: 32111518
[TBL] [Abstract][Full Text] [Related]
14. Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
Socinski MA; Smit EF; Lorigan P; Konduri K; Reck M; Szczesna A; Blakely J; Serwatowski P; Karaseva NA; Ciuleanu T; Jassem J; Dediu M; Hong S; Visseren-Grul C; Hanauske AR; Obasaju CK; Guba SC; Thatcher N
J Clin Oncol; 2009 Oct; 27(28):4787-92. PubMed ID: 19720897
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of carboplatin combined with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer.
Takeoka H; Yamada K; Azuma K; Zaizen Y; Yamashita F; Yoshida T; Naito Y; Okayama Y; Miyamoto M; Hoshino T
Jpn J Clin Oncol; 2014 May; 44(5):472-8. PubMed ID: 24688087
[TBL] [Abstract][Full Text] [Related]
17. Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients.
Takeoka H; Yamada K; Naito Y; Matsuo N; Ishii H; Tokito T; Azuma K; Ichiki M; Hoshino T
Anticancer Res; 2018 Jun; 38(6):3779-3784. PubMed ID: 29848743
[TBL] [Abstract][Full Text] [Related]
18. 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.
Borghaei H; Langer CJ; Gadgeel S; Papadimitrakopoulou VA; Patnaik A; Powell SF; Gentzler RD; Martins RG; Stevenson JP; Jalal SI; Panwalkar A; Yang JC; Gubens M; Sequist LV; Awad MM; Fiore J; Saraf S; Keller SM; Gandhi L
J Thorac Oncol; 2019 Jan; 14(1):124-129. PubMed ID: 30138764
[TBL] [Abstract][Full Text] [Related]
19. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancer.
Soria JC; Adjei AA; Bahleda R; Besse B; Ferte C; Planchard D; Zhou J; Ware J; Morrissey K; Shankar G; Lin W; Schutzman JL; Dy GK; Groen HJM
Eur J Cancer; 2017 Nov; 86():186-196. PubMed ID: 28992562
[TBL] [Abstract][Full Text] [Related]
20. Percentage Change in Plasma Cytokeratin 18 Is Associated with Clinical Outcomes in Patients Receiving Pemetrexed and Carboplatin for the Adenocarcinoma Subtype of NSCLC.
Strimpakos AS; Banerji U; Thavasu P; Tsilimagou A; Psyrri A; Syrigos KN
Oncology; 2015; 89(1):53-9. PubMed ID: 25766505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
